Chemically modified curcumin (CMC2.24) alleviates osteoarthritis progression by restoring cartilage homeostasis and inhibiting chondrocyte apoptosis via the NF-κB/HIF-2α axis
| Autor: | Shiqing Liu, Zhonghui Chen, Yan Zhou, Yaming Li, Yonggang Ma, Guirong Wang, Ming Deng, Jia Li, Jianghua Ming, Bochun Li |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Cartilage
Articular Curcumin education Anti-Inflammatory Agents Apoptosis Chondrocyte Extracellular matrix 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Chondrocytes Drug Discovery Osteoarthritis medicine Basic Helix-Loop-Helix Transcription Factors Animals Viability assay Genetics (clinical) Cartilage homeostasis NF-kappa B NF-κB Cell biology Extracellular Matrix Rats IκBα medicine.anatomical_structure chemistry Molecular Medicine human activities 030215 immunology Signal Transduction |
| Zdroj: | Journal of molecular medicine (Berlin, Germany). 98(10) |
| ISSN: | 1432-1440 |
| Popis: | The disorders of cartilage homeostasis and chondrocyte apoptosis are major events in the pathogenesis of osteoarthritis (OA). Herein, we aim to assess the chondroprotective effect and underlying mechanisms of a novel chemically modified curcumin, CMC2.24, in modulating extracellular matrix (ECM) homeostasis and inhibiting chondrocyte apoptosis. Rats underwent the anterior cruciate ligament transection, and medial menisci resection was treated by intra-articular injection with CMC2.24. In an in vitro study, rat chondrocytes were pretreated with CMC2.24 before stimulation with sodium nitroprusside (SNP). Results from in vivo studies demonstrated that the intra-articular administration of CMC2.24 ameliorated osteoarthritic cartilage destruction by promoting collagen 2a1 production and inhibited cartilage degradation and apoptosis by suppressing hypoxia-inducible factor-2a (Hif-2α), matrix metalloproteinase-3, runt-related transcription factor 2, cleaved caspase-3, and vascular endothelial growth factor and the phosphorylation of IκBα and NF-κB p65. The in vitro results revealed that CMC2.24 exhibited a strong inhibitory effect on SNP-induced chondrocyte catabolism and apoptosis. The SNP-enhanced expression of Hif-2α, a catabolic and apoptotic factor, decreased in a dose-dependent manner after CMC2.24 treatment. CMC2.24 pretreatment effectively inhibited SNP-induced IκBα and NF-κB p65 phosphorylation in rat chondrocytes, whereas pretreatment with the NF-κB antagonist BMS-345541 significantly enhanced the effects of CMC2.24. Overall, these results demonstrated that CMC2.24 attenuates OA progression by modulating ECM homeostasis and chondrocyte apoptosis by suppressing the NF-κB/Hif-2α axis, thus providing a new perspective for therapeutic strategies in OA. KEY MESSAGES: • Intra-articular injection of CMC2.24 ameliorated osteoarthritic cartilage destruction. • CMC2.24 promoted cell viability and decreased SNP-induced apoptotic gene expression. • SNP-induced activation of Hif-2α is inhibited by CMC2.24. • CMC2.24 inhibits NF-κB/Hif-2α axis activation to modulate ECM homeostasis and inhibit chondrocyte apoptosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink